Lsr2 acts as a cyclic di-GMP receptor that promotes keto-mycolic acid synthesis and biofilm formation in mycobacteria.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
24 Jan 2024
24 Jan 2024
Historique:
received:
29
05
2023
accepted:
03
01
2024
medline:
25
1
2024
pubmed:
25
1
2024
entrez:
24
1
2024
Statut:
epublish
Résumé
Cyclic di-GMP (c-di-GMP) is a second messenger that promotes biofilm formation in several bacterial species, but the mechanisms are often unclear. Here, we report that c-di-GMP promotes biofilm formation in mycobacteria in a manner dependent on the nucleoid-associated protein Lsr2. We show that c-di-GMP specifically binds to Lsr2 at a ratio of 1:1. Lsr2 upregulates the expression of HadD, a (3R)-hydroxyacyl-ACP dehydratase, thus promoting the synthesis of keto-mycolic acid and biofilm formation. Thus, Lsr2 acts as a c-di-GMP receptor that links the second messenger's function to lipid synthesis and biofilm formation in mycobacteria.
Identifiants
pubmed: 38267428
doi: 10.1038/s41467-024-44774-6
pii: 10.1038/s41467-024-44774-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
695Informations de copyright
© 2024. The Author(s).
Références
Monds, R. D., Newell, P. D., Gross, R. H. & O’Toole, G. A. Phosphate-dependent modulation of c-di-GMP levels regulates Pseudomonas fluorescens Pf0-1 biofilm formation by controlling secretion of the adhesin LapA. Mol. Microbiol. 63, 656–679 (2007).
pubmed: 17302799
doi: 10.1111/j.1365-2958.2006.05539.x
Boehm, A. et al. Second messenger-mediated adjustment of bacterial swimming velocity. Cell 141, 107–116 (2010).
pubmed: 20303158
doi: 10.1016/j.cell.2010.01.018
Wang, Z. et al. A c-di-GMP signaling cascade controls motility, biofilm formation, and virulence in Burkholderia thailandensis. Appl. Environ. Microbiol. 88, e0252921 (2022).
Martinez-Mendez, R., Camacho-Hernandez, D. A., Sulvaran-Guel, E. & Zamorano-Sanchez, D. A trigger phosphodiesterase modulates the global c-di-GMP pool, motility, and biofilm formation in Vibrio parahaemolyticus. J. Bacteriol. 203, e0004621 (2021).
Guo, Q. et al. Elongation factor P modulates Acinetobacter baumannii physiology and virulence as a cyclic dimeric guanosine monophosphate effector. Proc. Natl Acad. Sci. USA 119, e2209838119 (2022).
Liu, C. et al. cAMP and c-di-GMP synergistically support biofilm maintenance through the direct interaction of their effectors. Nat. Commun. 13, 1493 (2022).
pubmed: 35315431
pmcid: 8938473
doi: 10.1038/s41467-022-29240-5
Esteban, J. & Garcia-Coca, M. Mycobacterium biofilms. Front. Microbiol. 8, 2651 (2017).
pubmed: 29403446
doi: 10.3389/fmicb.2017.02651
Ackart, D. F. et al. Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis. Pathog. Dis. 70, 359–369 (2014).
pubmed: 24478060
doi: 10.1111/2049-632X.12144
Liu, J., Rosenberg, E. Y. & Nikaido, H. Fluidity of the lipid domain of cell wall from Mycobacterium chelonae. Proc. Natl Acad. Sci. USA 92, 11254–11258 (1995).
pubmed: 7479975
pmcid: 40610
doi: 10.1073/pnas.92.24.11254
Recht, J. & Kolter, R. Glycopeptidolipid acetylation affects sliding motility and biofilm formation in Mycobacterium smegmatis. J. Bacteriol. 183, 5718–5724 (2001).
pubmed: 11544235
pmcid: 95464
doi: 10.1128/JB.183.19.5718-5724.2001
Ghosh, S., Indi, S. S. & Nagaraja, V. Regulation of lipid biosynthesis, sliding motility, and biofilm formation by a membrane-anchored nucleoid-associated protein of Mycobacterium tuberculosis. J. Bacteriol. 195, 1769–1778 (2013).
pubmed: 23396914
pmcid: 3624558
doi: 10.1128/JB.02081-12
Pacheco, S. A., Hsu, F. F., Powers, K. M. & Purdy, G. E. MmpL11 protein transports mycolic acid-containing lipids to the mycobacterial cell wall and contributes to biofilm formation in Mycobacterium smegmatis. J. Biol. Chem. 288, 24213–24222 (2013).
pubmed: 23836904
pmcid: 3745366
doi: 10.1074/jbc.M113.473371
Ojha, A. et al. GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell 123, 861–873 (2005).
pubmed: 16325580
doi: 10.1016/j.cell.2005.09.012
Ojha, A. K. et al. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol. Microbiol. 69, 164–174 (2008).
pubmed: 18466296
pmcid: 2615189
doi: 10.1111/j.1365-2958.2008.06274.x
Cruz-Villegas, M. A. et al. Transcriptional and mycolic acid profiling in Mycobacterium bovis BCG in vitro show an effect for c-di-GMP and overlap between dormancy and biofilms. J. Microbiol. Biotechnol. 30, 811–821 (2020).
pubmed: 32238759
doi: 10.4014/jmb.1911.11043
Kolodziej, M. et al. Lsr2 and its novel paralogue mediate the adjustment of Mycobacterium smegmatis to unfavorable environmental conditions. mSphere 6, e00290–21 (2021).
Chen, J. M. et al. Lsr2 of Mycobacterium tuberculosis is a DNA-bridging protein. Nucleic Acids Res. 36, 2123–2135 (2008).
pubmed: 18187505
pmcid: 2367712
doi: 10.1093/nar/gkm1162
Gordon, B. R. et al. Lsr2 is a nucleoid-associated protein that targets AT-rich sequences and virulence genes in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 107, 5154–5159 (2010).
pubmed: 20133735
pmcid: 2841939
doi: 10.1073/pnas.0913551107
Chen, J. M. et al. Roles of Lsr2 in colony morphology and biofilm formation of Mycobacterium smegmatis. J. Bacteriol. 188, 633–641 (2006).
pubmed: 16385053
pmcid: 1347275
doi: 10.1128/JB.188.2.633-641.2006
Yang, Y. et al. Defining a temporal order of genetic requirements for development of mycobacterial biofilms. Mol. Microbiol. 105, 794–809 (2017).
pubmed: 28628249
pmcid: 5607029
doi: 10.1111/mmi.13734
Baez-Ramirez, E. et al. Elimination of PknL and MSMEG_4242 in Mycobacterium smegmatis alters the character of the outer cell envelope and selects for mutations in Lsr2. Cell Surf. 7, 100060 (2021).
Flores-Valdez, M. A. et al. Transcriptional portrait of M. bovis BCG during biofilm production shows genes differentially expressed during intercellular aggregation and substrate attachment. Sci. Rep. 10, 12578 (2020).
pubmed: 32724037
pmcid: 7387457
doi: 10.1038/s41598-020-69152-2
Kolodziej, M. et al. Lsr2, a nucleoid-associated protein influencing mycobacterial cell cycle. Sci. Rep. 11, 2910 (2021).
pubmed: 33536448
pmcid: 7858621
doi: 10.1038/s41598-021-82295-0
Colangeli, R. et al. Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M. tuberculosis. PLoS Pathog. 3, e87 (2007).
pubmed: 17590082
pmcid: 1894825
doi: 10.1371/journal.ppat.0030087
Bartek, I. L. et al. Mycobacterium tuberculosis Lsr2 is a global transcriptional regulator required for adaptation to changing oxygen levels and virulence. mBio 5, e01106–e01114 (2014).
pubmed: 24895305
pmcid: 4049101
doi: 10.1128/mBio.01106-14
Lefebvre, C. et al. HadD, a novel fatty acid synthase type II protein, is essential for alpha- and epoxy-mycolic acid biosynthesis and mycobacterial fitness. Sci. Rep. 8, 6034 (2018).
pubmed: 29662082
pmcid: 5902629
doi: 10.1038/s41598-018-24380-5
Lefebvre, C. et al. Discovery of a novel dehydratase of the fatty acid synthase type II critical for ketomycolic acid biosynthesis and virulence of Mycobacterium tuberculosis. Sci. Rep. 10, 2112 (2020).
pubmed: 32034201
pmcid: 7005898
doi: 10.1038/s41598-020-58967-8
Li, W. & He, Z. G. LtmA, a novel cyclic di-GMP-responsive activator, broadly regulates the expression of lipid transport and metabolism genes in Mycobacterium smegmatis. Nucleic Acids Res. 40, 11292–11307 (2012).
pubmed: 23047950
pmcid: 3526308
doi: 10.1093/nar/gks923
Agusti, G., Astola, O., Rodriguez-Guell, E., Julian, E. & Luquin, M. Surface spreading motility shown by a group of phylogenetically related, rapidly growing pigmented mycobacteria suggests that motility is a common property of mycobacterial species but is restricted to smooth colonies. J. Bacteriol. 190, 6894–6902 (2008).
pubmed: 18689490
pmcid: 2566177
doi: 10.1128/JB.00572-08
Qi, L. S. et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173–1183 (2013).
pubmed: 23452860
pmcid: 3664290
doi: 10.1016/j.cell.2013.02.022
Rock, J. M. et al. Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform. Nat. Microbiol. 2, 16274 (2017).
pubmed: 28165460
pmcid: 5302332
doi: 10.1038/nmicrobiol.2016.274
Liu, J. & Gordon, B. R. Targeting the global regulator Lsr2 as a novel approach for anti-tuberculosis drug development. Expert Rev. Anti Infect. Ther. 10, 1049–1053 (2012).
pubmed: 23106279
doi: 10.1586/eri.12.86
Bridges, A. A., Fei, C. & Bassler, B. L. Identification of signaling pathways, matrix-digestion enzymes, and motility components controlling Vibrio cholerae biofilm dispersal. Proc. Natl Acad. Sci. USA 117, 32639–32647 (2020).
pubmed: 33288715
pmcid: 7768729
doi: 10.1073/pnas.2021166117
Hengge, R. Principles of c-di-GMP signalling in bacteria. Nat. Rev. Microbiol. 7, 263–273 (2009).
pubmed: 19287449
doi: 10.1038/nrmicro2109
Li, W. et al. Cyclic diguanylate monophosphate directly binds to human siderocalin and inhibits its antibacterial activity. Nat. Commun. 6, 8330 (2015).
pubmed: 26390966
doi: 10.1038/ncomms9330
Li, W. et al. HpoR, a novel c-di-GMP effective transcription factor, links the second messenger’s regulatory function to the mycobacterial antioxidant defense. Nucleic Acids Res. 46, 3595–3611 (2018).
pubmed: 29490073
pmcid: 5909442
doi: 10.1093/nar/gky146
Hu, Q. et al. Cyclic di-GMP co-activates the two-component transcriptional regulator DevR in Mycobacterium smegmatis in response to oxidative stress. J. Biol. Chem. 294, 12729–12742 (2019).
pubmed: 31270210
pmcid: 6709620
doi: 10.1074/jbc.RA119.008252
Schiessl, K. T. et al. Phenazine production promotes antibiotic tolerance and metabolic heterogeneity in Pseudomonas aeruginosa biofilms. Nat. Commun. 10, 762 (2019).
pubmed: 30770834
pmcid: 6377615
doi: 10.1038/s41467-019-08733-w
Ciofu, O., Moser, C., Jensen, P. O. & Hoiby, N. Tolerance and resistance of microbial biofilms. Nat. Rev. Microbiol. 20, 621–635 (2022).
pubmed: 35115704
doi: 10.1038/s41579-022-00682-4
Behzadi, P. et al. Relationship between biofilm-formation, phenotypic virulence factors and antibiotic resistance in environmental Pseudomonas aeruginosa. Pathogens 11, 1015 (2022).
Rabin, N. et al. Biofilm formation mechanisms and targets for developing antibiofilm agents. Future Med. Chem. 7, 493–512 (2015).
pubmed: 25875875
doi: 10.4155/fmc.15.6
Makabenta, J. M. V. et al. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nat. Rev. Microbiol. 19, 23–36 (2021).
pubmed: 32814862
doi: 10.1038/s41579-020-0420-1
Singh, P. K. et al. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 407, 762–764 (2000).
pubmed: 11048725
doi: 10.1038/35037627
Chakraborty, P., Bajeli, S., Kaushal, D., Radotra, B. D. & Kumar, A. Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis. Nat. Commun. 12, 1606 (2021).
pubmed: 33707445
pmcid: 7952908
doi: 10.1038/s41467-021-21748-6
Chakraborty, P. & Kumar, A. The extracellular matrix of mycobacterial biofilms: could we shorten the treatment of mycobacterial infections? Micro. Cell 6, 105–122 (2019).
doi: 10.15698/mic2019.02.667
Dulberger, C. L., Rubin, E. J. & Boutte, C. C. The mycobacterial cell envelope—a moving target. Nat. Rev. Microbiol. 18, 47–59 (2020).
pubmed: 31728063
doi: 10.1038/s41579-019-0273-7
Grzegorzewicz, A. E. et al. Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nat. Chem. Biol. 8, 334–341 (2012).
pubmed: 22344175
pmcid: 3307863
doi: 10.1038/nchembio.794
Xu, H., Su, Z., Li, W., Deng, Y. & He, Z. G. MmbR, a master transcription regulator that controls fatty acid beta-oxidation genes in Mycolicibacterium smegmatis. Environ. Microbiol. 23, 1096–1114 (2021).
pubmed: 32985741
doi: 10.1111/1462-2920.15249
Blokpoel, M. C. et al. Tetracycline-inducible gene regulation in mycobacteria. Nucleic Acids Res. 33, e22 (2005).
pubmed: 15687380
pmcid: 548381
doi: 10.1093/nar/gni023
Yang, M., Gao, C., Cui, T., An, J. & He, Z. G. A TetR-like regulator broadly affects the expressions of diverse genes in Mycobacterium smegmatis. Nucleic Acids Res. 40, 1009–1020 (2012).
pubmed: 21976733
doi: 10.1093/nar/gkr830
Wang, Y., Huang, Y., Xue, C., He, Y. & He, Z. G. ClpR protein-like regulator specifically recognizes RecA protein-independent promoter motif and broadly regulates expression of DNA damage-inducible genes in mycobacteria. J. Biol. Chem. 286, 31159–31167 (2011).
pubmed: 21771781
pmcid: 3173126
doi: 10.1074/jbc.M111.241802
Li, W. et al. Cyclic di-GMP integrates functionally divergent transcription factors into a regulation pathway for antioxidant defense. Nucleic Acids Res. 46, 7270–7283 (2018).
pubmed: 29982829
pmcid: 6101608
doi: 10.1093/nar/gky611
Frank, S. R., Schroeder, M., Fernandez, P., Taubert, S. & Amati, B. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 15, 2069–2082 (2001).
pubmed: 11511539
pmcid: 312758
doi: 10.1101/gad.906601
Weinhouse, H. et al. c-di-GMP-binding protein, a new factor regulating cellulose synthesis in Acetobacter xylinum. FEBS Lett. 416, 207–211 (1997).
pubmed: 9369216
doi: 10.1016/S0014-5793(97)01202-7
Stover, C. K. et al. New use of BCG for recombinant vaccines. Nature 351, 456–460 (1991).
pubmed: 1904554
doi: 10.1038/351456a0